Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Matti Aapro, Alessandra Fabi, Franco Nolè, +5

Annals of Oncology

Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

R. Jakesz, H. Hausmaninger, H. Samonigg, +11

European Journal of Cancer

Breast OncologyMedicineClinical TrialsGynecologyFour-year Results +9

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

Flora Zagouri, Theodoros Ν. Sergentanis, Vassilis Koutoulidis, +7

British Journal of Cancer

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial

CC Zielinski, Boye Schnack, M Grbovic, +5

British Journal of Cancer

Metastatic Urothelial CancerUrologyPhase Ii TrialGenitourinary CancerMedicine +4

Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience

G.G. Steger, Rupert Bartsch, C. Wenzel, +7

European Journal of Cancer

Advanced Breast CancerBreast OncologyMedicineSingle-centre ExperienceBreast Cancer +5

Abstract S2-02: The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial

Michael Gnant, G Pfeiler, P Dubsky, +23

Cancer Research

Breast OncologyDisease ProgressionAdjuvant DenosumabAbstract S2-02Pharmacotherapy +16

The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma

G.G. Steger, R Kaboo, J B deKernion, +2

British Journal of Cancer

Cancer ImmunosurveillanceGenitourinary CancerGranulocyteImmunologyPathology +6

Karyotype and prognosis in non-Hodgkin lymphoma.

Hendrati Pirc‐Danoewinata, Andreas Chott, E Onderka, +7

PubMed

GM‐CSF in the treatment of a patient with severe methotrexate intoxication

G.G. Steger, Robert M. Mader, Michael Gnant, +3

Journal of Internal Medicine

P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.

A. Stopeck, Allan Lipton, Miguel Martín, +12

Cancer Research

Zoledronic AcidBreast OncologyOncologyCancer ManagementMetronomic Therapy +12